Welcome : Guest

Inotek Pharmaceuticals Corporation (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Inotek Pharmaceuticals Corporation, which is principally involved in Clinical-Stage Biopharmaceuticals Business. Illustrated with 16 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-64642
Price: $800
Company Type: Public
Pages: 18
Date: November 2016
Market Data Tables: 16

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Therapeutic Drugs......3
Table 1: Therapeutic Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Cancer/Onc./Hem., Cardiology, CNS, Dermatology, Diabetes, GI/Ulcer, Infectious Disease, Multiple Sclerosis, Ophthalmology, Respiratory, Rheumatology, Women's Health, and Others......3
Ophthalmic Drugs......4
Table 2: Ophthalmic Antibiotic Drug Market in the US (2015) - Percentage Market Share Breakdown by Value for Besivance, Moxeza, Vigamox, Zymaxid and Generic & Others......4
Table 3: Ophthalmic Steroid Drug Market in the US (2015) - Percentage Market Share Breakdown by Value for Alrex, Durezol, Lotemax, Ozurdex and Generic & Others......5
Glaucoma......6
Table 4: Glaucoma Disease Market for Prostaglandin Analogs (PGAs) by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Latanoprost, Lumigan, Travatan and Others......6
Table 5: Glaucoma Disease Market for Non Prostaglandin Analogs (Non-PGAs) by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Alpha Agonist, Beta Blockers (alone), Beta Blockers (combo), Canbone Anymore and Others......7
Table 6: Glaucoma Market by Product in the US (2015) - Percentage Share Breakdown by Value for Alpha Agonist, Beta Blocker, Beta Blocker Fixed Combo, Bimatoprost (Lumigan), Carbonic Anhydrase Inhibitor, Latanoprost (Xalatan, Generics), Travoprost (Travatan), and Others......8
Glaucoma Drugs......9
Table 7: Glaucoma Drugs Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Alpha Agonists (AA), Beta Blocker Fixed Combos (BB-FC), Beta Blockers (BB), Carboic Anhydrase Inhibitors (CAI) and Prostaglandins (PGA)......9
Ophthalmology......10
Table 8: Ophthalmology Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Ophthalmic pharmaceuticals, Surgical, and Vision Care......10
Table 9: Ophthalmology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Cataract & Vitreoretinal Surgery, Ophthalmic Lasers, and Vision Care......11
Visual Impairment......12
Table 10: Visual Impairment Market by Category in Germany (2015) - Percentage Market Share Breakdown by Value for Cataract, Glaucoma, Uncorr Refrerrors, and Others......12
Table 11: Visual Impairment Market by Age Group in Germany (2015) - Percentage Market Share Breakdown by Value for 0-14, 15-49, and 50 and Olders......13
Ophthalmology Drugs......14
Table 12: Market Shares of Leading Ophthalmology Therapeutic Providers by Value Sales Worldwide (2015) - Percentage Breakdown for F. Hoffmann-La Roche AG, Merck Ltd., Novartis AG, Pfizer, Inc., and Others......14
Table 13: Market Shares of Leading Ophthalmic Steroids Brands in the US (2015) - Percentage Share Breakdown by Value for Fluorometholone, Lotemax, Prednisolone and Others......15
Retinal......16
Table 14: Market Shares of Leading Retinal Companies Worldwide (2014) - Percentage Share Breakdown by Value for Alcon Incorporated, Bausch & Lomb, Dutch Ophthalmic Research Center International BV, Iridex Corporation, Synergetics, Inc., and Others......16
Vision Care......17
Table 15: Market Shares of Leading Vision Care Carriers Worldwide (2015) - Percentage Share Breakdown by Value for Davis Optical, Inc., EyeMed Vision Care, OptumHealth Care Solutions, Inc., VSP Vision Care, and Others......17
Therapeutic Drugs......18
Table 16: Market Shares of Leading Therapeutic Providers (Alzheimer's Disease, Bone Diseases, Cardiology, CNS, Dermatology, Diabetes/Metabolic, Epilepsy, G.I./Ulcer, HBV/HCV, Infectious Disease, Multiple Sclerosis, Obesity, Onc./Hematology, Ophthalmology, Orphan Disease, Pain Management, Respiratory, Rheumatology, Sleep Disorders, Urinary Incont., and Women's Health) by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Biogen Idec, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Endo International Plc, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......18